Estimation of the neurovirulence of poliovirus by non-radioisotope molecular analysis to quantify genomic changes.
Mutant analysis by polymerase chain reaction and restriction enzyme cleavage (MAPREC) has been developed for poliovirus to determine quantitatively for the presence of genomic changes in particular nucleotide sequences correlate with the characteristic of neurovirulence for monkeys. Currently the MAPREC is scheduled to be used as a routine safety test for oral poliomyelitis vaccine (OPV). Radioisotopes (RI) are used in MAPREC for quantitative determinations, a circumstance likely to limit its use. We investigated the possibility of developing a modified MAPREC, which did not require the use of radioisotopes, and developed a procedure designated NON-RI MAPREC. Conventional MAPREC and NON-RI MAPREC were then used in a series of studies in which analyses were performed on Sabin type 1 and Sabin type 3 attenuated vaccine polioviruses prepared under various conditions. Under the experimental conditions used, the stability of the genome of type 1 virus was shown to be markedly greater than that of the type 3 virus, and the frequency of mutants was observed to vary in relation to both the virus strain and the virus inoculum used. The results of the studies relating to the two analytical procedures used indicated that the reproducibility of both methods was of a similarly high order, but that MAPREC had a somewhat broader range of sensitivity than NON-RI MAPREC. As the quantity of genomic changes in OPV relating to neurovirulent properties are within the range of detection by NON-RI MAPREC, this procedure can be used as a quality control test for OPV.
Japan Poliomyelitis Research Institute, Tokyo, Japan.
H
H
Horie
Y
Y
Tano
Y
Y
Doi
S
S
Hashizume
D000818:Animals; D002138:Calibration; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D004262:DNA Restriction Enzymes; D016679:Genome, Viral; D006801:Humans; D017955:Poliovirus / Q000235:genetics* / Q000472:pathogenicity*; D011055:Poliovirus Vaccine, Oral / Q000235:genetics*; D016133:Polymerase Chain Reaction / Q000379:methods*; D013696:Temperature; D014774:Virulence; D014944:World Health Organization
D011055:Poliovirus Vaccine, Oral; D004262:DNA Restriction Enzymes